ASLAN Pharmaceuticals

Quick facts

Phase 2 pipeline

• ASLAN003 · Oncology
  ASLAN003 is a monoclonal antibody targeting the PD-1 receptor.
• ASLAN004
• Farudodstat · Other

Phase 1 pipeline

• ASLAN003 ACTIVE

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• ASLAN Pharmaceuticals portfolio CI brief
• ASLAN Pharmaceuticals pipeline updates RSS